Live Breaking News & Updates on News Ratings For Harrow Health Daily

Stay updated with breaking news from News ratings for harrow health daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Buys 29,400 Shares

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) major shareholder Opaleye Management Inc. purchased 29,400 shares of Harrow Health stock in a transaction dated Friday, April 19th. The shares were acquired at an average cost of $10.56 per share, for a total transaction of $310,464.00. Following the transaction, the insider now directly owns 3,775,000 shares […] ....

Craig Hallum , Institutional Trading Of Harrow Health , Eton Pharmaceuticals Inc , Harrow Health , Envestnet Asset Management Inc , Surface Ophthalmics Inc , Securities Exchange Commission , Wasatch Advisors Inc , Opaleye Management Inc , Harrow Health Inc , Prelude Capital Management , Pharmaceuticals Inc , Quarter For Harrow Health , Harrow Health Stock Down , News Ratings For Harrow Health Daily , Blackrock Inc , Get Free Report , Opaleye Management , Exchange Commission , Health Stock Down , Asset Management , Capital Management , State Street Corp , Street Corp , Surface Ophthalmics , Melt Pharmaceuticals ,

Harrow Health, Inc. (NASDAQ:HROW) CEO Buys $104,310.00 in Stock

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) CEO Mark L. Baum acquired 9,000 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of $11.59 per share, for a total transaction of $104,310.00. Following the completion of the acquisition, the chief executive officer now […] ....

Markl Baum , Surface Ophthalmics Inc , Rice Hall James Associates , Harrow Health Company Profile , Jump Financial , Stifel Financial Corp , Harrow Health , Kennedy Capital Management , Pharmaceuticals Inc , News Ratings For Harrow Health Daily , Harrow Health Stock , Harrow Health Inc , Institutional Investors Weigh In On Harrow Health , Eton Pharmaceuticals Inc , Get Free Report , Capital Management , Financial Corp , Hall James , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow , Insider Trading , Nsider Trades ,

Harrow Health, Inc. Expected to Post Q1 2024 Earnings of ($0.25) Per Share (NASDAQ:HROW)

Harrow Health, Inc. Expected to Post Q1 2024 Earnings of ($0.25) Per Share (NASDAQ:HROW)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Markl Baum , Harrow Health Trading , Institutional Trading Of Harrow Health , Blackrock Inc , Vanguard Group Inc , Pharmaceuticals Inc , Harrow Health , Opaleye Management Inc , Morgan Stanley , Insider Activity At Harrow Health , Securities Exchange Commission , Eton Pharmaceuticals Inc , Surface Ophthalmics Inc , News Ratings For Harrow Health Daily , Harrow Health Inc , Free Report , Exchange Commission , Opaleye Management , Get Free Report , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily ,

Harrow Health, Inc. (NASDAQ:HROW) Expected to Earn Q1 2024 Earnings of ($0.25) Per Share

Harrow Health, Inc. (NASDAQ:HROW – Free Report) – Investment analysts at B. Riley issued their Q1 2024 earnings per share estimates for shares of Harrow Health in a research note issued to investors on Thursday, March 21st. B. Riley analyst M. Mamtani forecasts that the company will post earnings of ($0.25) per share for the […] ....

Eton Pharmaceuticals Inc , Goldman Sachs Group Inc , Harrow Health , Nuveen Asset Management , Harrow Health Stock , Barclays Plc , Surface Ophthalmics Inc , Pricet Rowe Associates Inc , News Ratings For Harrow Health Daily , Vanguard Group Inc , Hedge Funds Weigh In On Harrow Health , Opaleye Management Inc , Harrow Health Inc , Pharmaceuticals Inc , Free Report , Sachs Group , Asset Management , Opaleye Management , Get Free Report , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily ,

Paradigm Capital Management Inc. NY Acquires New Position in Harrow Health, Inc. (NASDAQ:HROW)

Paradigm Capital Management Inc. NY Acquires New Position in Harrow Health, Inc. (NASDAQ:HROW)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Harrow Health Inc , Quarter For Harrow Health , News Ratings For Harrow Health Daily , Pharmaceuticals Inc , Surface Ophthalmics Inc , Harrow Health , Prelude Capital Management , Eton Pharmaceuticals Inc , Harrow Health Trading , Wasatch Advisors Inc , Harrow Health Profile , Paradigm Capital Management Inc , Envestnet Asset Management Inc , Exchange Commission , Blackrock Inc , Paradigm Capital Management , Free Report , Capital Management , Asset Management , State Street Corp , Street Corp , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily ,